Public meetings for cannabis-related policymaking remained uncertain at the start of another week under the pall of COVID-19, but some agencies pushed ahead with telepresence.
Where does all the cannabis money go? Taxes from cannabis sales were utilized for a multitude of purposes and cannabis-related policymaking was funded by the Legislature.
With the close of the legislative session and restrictions on public movement tightening against the spread of COVID-19, cannabis policymaking appeared set to slow if not pause altogether.
The SBOH renewed their emergency rule against use of vitamin E acetate in vapor products and expressed concern about prospects for SB 6254, the Governor’s vapor product legislation.
The Board cancelled the March 18th Board Meeting, rescheduled the Quality Control public hearing, and learned about the surprising fate of the agency’s social equity legislation.
Five cannabis-related bills and the supplemental operating budget remain active as the Washington State Legislature’s short session draws to a close on Thursday.
The Senate fiscal committee passed HB 2826, WSLCB’s cannabis vapor products bill, as well as SB 6254, DOH’s vapor products bill which had been repeatedly brought “back to life.”
Discussion of “problematic” budget provisos and a review of what happened with HB 2870 engaged the Board while concerns about COVID-19 began to spread.